Collegium Pharmaceutical Inc (COLL) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Collegium Pharmaceutical Inc   (NASDAQ: COLL)


Collegium Pharmaceutical Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Collegium Pharmaceutical Inc's ROI in the second quarter of 2026?
Collegium Pharmaceutical Inc achieved a return on average invested assets (ROI) of 3.73 % in its second quarter of 2026, this is above COLL's average return on investment of -7.92%.
Collegium Pharmaceutical Inc invested over the 12 months ending in its second quarter of 2026 $1,284 million

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 151 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 747 to 1318.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 11.55 % 16.15 % 29.8 % 47.64 % 74.74 %
Y / Y Net Income Change TTM 32.1 % 70.75 % 51.58 % 101.94 % 85 %
Investment (TTM) in Millions 1,546 1,217 1,217 1,154 1,128
Return On Investment (TTM) 3.73 % 6.36 % 5.42 % 5.1 % 3.15 %
COLL's Overall Ranking # 1318 # 747 # 963 # 677 # 1263
Seq. Investment Change TTM 8.86 % 1.56 % 1.37 % -0.46 % 13.35 %
Seq. Net Income Change TTM -36.07 % 19.21 % 7.57 % 61.13 % -17.37 %
Net Income (TTM) in Millions 48 75 63 58 36

COLL Company Profile >> Back to COLL Roi Comparisons >> See Annual COLL Return On Investment



Return On Investment COLL's Ranking
Within: No.
Industry # 53
Sector # 152
Overall # 1318

Return On Investment Statistics
High Average Low
24.99 %
-7.92 %
-57.29 %
(Jun 30 2021)   (Mar 31 2017)







Financial Statements
Collegium Pharmaceutical Inc's II. Quarter Investments $ 1,546 Millions COLL's Balance sheet
Collegium Pharmaceutical Inc's II. Quarter Income $ -15 Millions Quarterly COLL's Income Statement
COLL's Income by Division See COLL's Income by Division


COLL Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,217 1,154 679 733 405
Y / Y Investment Growth 5.44 % 69.9 % -7.37 % 81.26 % 2.26 %
Net Income in Millions 63 69 48 -25 72
Y / Y Net Income Growth -9.13 % 43.68 % - - 167.33 %
Annual Return On Investment 5.17 % 6 % 7.09 % -3.41 % 17.68 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 5.17 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
COLL's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for COLL's Competitors
Subscribers only: Roi for Collegium Pharmaceutical Inc's Suppliers
Subscribers only: Return On Investment for COLL's Customers

Other Ratios
COLL's Roa COLL's Inventory Turnover Ratio COLL's Growth Rates COLL's Dividend Statistics
COLL's Profitability Ratios COLL's Asset Turnover Ratio COLL's Dividend Growth
COLL's Roe COLL's Valuation Ratios COLL's Financial Strength Ratios COLL's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %
Tenet Healthcare Corp  9.98 %
Nature s Sunshine Products inc   9.91 %
Boston Scientific Corporation  9.91 %
Align Technology inc   9.50 %
Pediatrix Medical Group Inc   9.18 %
Abbvie Inc   9.11 %
Ani Pharmaceuticals Inc  9.09 %
Viemed Healthcare Inc   8.97 %
Stryker Corp  8.80 %
Penumbra Inc  8.71 %
Utah Medical Products Inc  8.70 %
Edwards Lifesciences Corporation  8.39 %
Veracyte Inc   8.15 %
Phibro Animal Health Corporation  8.11 %
Brightspring Health Services Inc   8.05 %
Quest Diagnostics Inc  8.05 %
Addus Homecare Corp  7.98 %
Corcept Therapeutics Inc  7.96 %
Amneal Pharmaceuticals Inc   7.91 %
Concentra Group Holdings Parent Inc   7.89 %
Bio techne Corp  7.61 %
Pacific Health Care Organization Inc  7.42 %
Davita Inc   6.92 %
Kewaunee Scientific Corporation  6.58 %
Medtronic Plc  6.46 %
Siga Technologies Inc  6.45 %

Date modified: 2026-09-26T07:20:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.